Logo image of AXGN

AXOGEN INC (AXGN) Stock Price, Quote, News and Overview

NASDAQ:AXGN - Nasdaq - US05463X1063 - Common Stock - Currency: USD

10.89  -0.01 (-0.09%)

After market: 10.89 0 (0%)

AXGN Quote, Performance and Key Statistics

AXOGEN INC

NASDAQ:AXGN (5/30/2025, 8:00:01 PM)

After market: 10.89 0 (0%)

10.89

-0.01 (-0.09%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High21
52 Week Low6.57
Market Cap495.93M
Shares45.54M
Float43.33M
Yearly DividendN/A
Dividend YieldN/A
PE64.06
Fwd PE22.48
Earnings (Next)08-06 2025-08-06/bmo
IPO12-17 1986-12-17


AXGN short term performance overview.The bars show the price performance of AXGN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

AXGN long term performance overview.The bars show the price performance of AXGN in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40 50

The current stock price of AXGN is 10.89 USD. In the past month the price decreased by -33.92%. In the past year, price increased by 59.44%.

AXOGEN INC / AXGN Daily stock chart

AXGN Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.95 232.41B
ISRG INTUITIVE SURGICAL INC 72.3 197.97B
BSX BOSTON SCIENTIFIC CORP 38.99 155.73B
SYK STRYKER CORP 30.54 146.23B
MDT MEDTRONIC PLC 15.09 106.43B
BDX BECTON DICKINSON AND CO 12.25 49.47B
EW EDWARDS LIFESCIENCES CORP 30.08 45.88B
IDXX IDEXX LABORATORIES INC 45.03 41.60B
RMD RESMED INC 26.96 35.89B
DXCM DEXCOM INC 52 33.64B
GEHC GE HEALTHCARE TECHNOLOGY 15.33 32.30B
STE STERIS PLC 26.25 24.09B

About AXGN

Company Profile

AXGN logo image Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 451 full-time employees. The company offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

Company Info

AXOGEN INC

Suite 100, 13859 Progress Blvd.

Alachua FLORIDA 32615 US

CEO: Karen Zaderej

Employees: 452

AXGN Company Website

AXGN Investor Relations

Phone: 13864626817

AXOGEN INC / AXGN FAQ

What is the stock price of AXOGEN INC today?

The current stock price of AXGN is 10.89 USD. The price decreased by -0.09% in the last trading session.


What is the ticker symbol for AXOGEN INC stock?

The exchange symbol of AXOGEN INC is AXGN and it is listed on the Nasdaq exchange.


On which exchange is AXGN stock listed?

AXGN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for AXOGEN INC stock?

14 analysts have analysed AXGN and the average price target is 26.65 USD. This implies a price increase of 144.7% is expected in the next year compared to the current price of 10.89. Check the AXOGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is AXOGEN INC worth?

AXOGEN INC (AXGN) has a market capitalization of 495.93M USD. This makes AXGN a Small Cap stock.


How many employees does AXOGEN INC have?

AXOGEN INC (AXGN) currently has 452 employees.


What are the support and resistance levels for AXOGEN INC (AXGN) stock?

AXOGEN INC (AXGN) has a support level at 10.88 and a resistance level at 11.84. Check the full technical report for a detailed analysis of AXGN support and resistance levels.


Is AXOGEN INC (AXGN) expected to grow?

The Revenue of AXOGEN INC (AXGN) is expected to grow by 16.24% in the next year. Check the estimates tab for more information on the AXGN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy AXOGEN INC (AXGN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AXOGEN INC (AXGN) stock pay dividends?

AXGN does not pay a dividend.


When does AXOGEN INC (AXGN) report earnings?

AXOGEN INC (AXGN) will report earnings on 2025-08-06, before the market open.


What is the Price/Earnings (PE) ratio of AXOGEN INC (AXGN)?

The PE ratio for AXOGEN INC (AXGN) is 64.06. This is based on the reported non-GAAP earnings per share of 0.17 and the current share price of 10.89 USD. Check the full fundamental report for a full analysis of the valuation metrics for AXGN.


What is the Short Interest ratio of AXOGEN INC (AXGN) stock?

The outstanding short interest for AXOGEN INC (AXGN) is 3.98% of its float. Check the ownership tab for more information on the AXGN short interest.


AXGN Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to AXGN. When comparing the yearly performance of all stocks, AXGN is one of the better performing stocks in the market, outperforming 73.36% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AXGN Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to AXGN. The financial health of AXGN is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AXGN Financial Highlights

Over the last trailing twelve months AXGN reported a non-GAAP Earnings per Share(EPS) of 0.17. The EPS increased by 221.43% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -3.65%
ROE -6.8%
Debt/Equity 0.45
Chartmill High Growth Momentum
EPS Q2Q%66.67%
Sales Q2Q%17.36%
EPS 1Y (TTM)221.43%
Revenue 1Y (TTM)18.81%

AXGN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to AXGN. The Buy consensus is the average rating of analysts ratings from 14 analysts.

For the next year, analysts expect an EPS growth of 67.38% and a revenue growth 16.24% for AXGN


Ownership
Inst Owners82.17%
Ins Owners1.68%
Short Float %3.98%
Short Ratio2.91
Analysts
Analysts84.29
Price Target26.65 (144.72%)
EPS Next Y67.38%
Revenue Next Year16.24%